Centessa Pharmaceuticals PLC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep CNTA

Logo korporat perusahaan Centessa Pharmaceuticals (CNTA)

Centessa Pharmaceuticals (CNTA) prospects are tied to orexin agonist clinical trials and FDA approval, and the annual EPS growth forecast generated by GURU.Markets currently shows a metric of -9.40. The biotech's results depend on biological factors rather than economic ones; meanwhile, high R&D intensity in the field of rare neurological pathologies paves the way for breakthrough medical discoveries.

Centessa Pharmaceuticals PLC (CNTA): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 04.07.2026

Ringkesan rincian data analitis Centessa Pharmaceuticals PLC (CNTA)

Analisis fundamental perusahaan:centessa.com, CNTA
Produk dadi Centessa Pharmaceuticals plc

This indicator measures the percentage deviation of the projected earnings per share for the next period from current values, reflecting the consensus estimate of market analysts. On the GURU.Markets platform, shifts in analyst expectations for EPS n+1 growth are critical for Centessa Pharmaceuticals (CNTA), as high R&D expenditures coupled with a revenue deficit make any positive forecasts the primary driver of future capitalization.

Analisis perusahaan pesaing

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Jazz Pharmaceuticals|CYTK: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PTC Bio (PTCT)|SRRK - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep dyne-tx.com DYN|Edgewise Corp - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|RAPP - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Alumis Inc.|ZVRA: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Contineum Pharma CTNM|Prakiraan wutah bathi saben saham kanggo taun ngarep LRMR|Prakiraan wutah bathi resik saben saham ing taun ngarep Capricor Therapeutics CAPR|Prakiraan wutah bathi kanggo taun ngarep TRDA|Prakiraan wutah bathi saben saham kanggo taun ngarep Channel Therapeutics PTHS|Prakiraan wutah bathi kanggo taun ngarep MNOV (MediciNova)|Dinamika bathi saben saham sing diarepake ing taun ngarep SER|BTAI - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|promisneurosciences.com (PMN) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Apimeds (APUS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep AEON|Prakiraan wutah bathi resik saben saham kanggo taun ngarep NLS Pharma|Prakiraan wutah bathi resik saben saham ing taun ngarep bionomics.com.au BNOX|Prakiraan wutah bathi kanggo taun ngarep HUGE|RETA (Reata Pharma) - Dinamika bathi saben saham sing diarepake ing taun ngarep